SCHEMBL8993178

SCHEMBL8993178

CCOC(=O)c1ccc(C(O)c2ccc(C)cc2)c(OC)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B2 P37059 1/20 0.57
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
KDM4E B2RXH2 3/20 0.45
POLB P06746 1/20 0.45
MAPT P10636 6/20 0.45
LMNA P02545 2/20 0.45
ALDH1A1 P00352 2/20 0.45
MAPK1 P28482 1/20 0.45
HPGD P15428 1/20 0.45
CA12 O43570 2/20 0.44
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA7 P43166 2/20 0.44
CA9 Q16790 2/20 0.44
CA14 Q9ULX7 2/20 0.44
TSHR P16473 2/20 0.44
CTNNB1 P35222 1/20 0.44
WNT3A P56704 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8992953 0.91 HSD17B2 (0.56) HSD17B2NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL8992796 0.84 HSD17B2 (0.59) HSD17B2NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL8992942 0.81 HSD17B2 (0.56) HSD17B2NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL6929080 0.76 HSD17B2 (0.59) HSD17B2NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL1660365 0.76 HSD17B2 (0.76) HSD17B2NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL30506315 0.76 HSD17B2 (0.76) HSD17B2NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL8133666 0.75 HSD17B2 (0.58) HSD17B2NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL310621 0.75 TSHR (0.71) HSD17B2NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL31474384 0.75 TSHR (0.71) HSD17B2NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL27603935 0.75 HSD17B2 (0.69) HSD17B2NPC1RAB9ASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5516777-A PROSTATE CANCER THERAPY OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1996-05-14 US disclosed
US-5409928-A Prostate diseases, alopecia OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-04-25 US disclosed
EP-0594149-A2 Condensed pyrazole derivatives, method of manufacturing the same, and androgen inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1994-04-27 EP disclosed